Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Biomarkers for smoking cessation.

Bough KJ, Lerman C, Rose JE, McClernon FJ, Kenny PJ, Tyndale RF, David SP, Stein EA, Uhl GR, Conti DV, Green C, Amur S.

Clin Pharmacol Ther. 2013 Jun;93(6):526-38. doi: 10.1038/clpt.2013.57. Review.

2.

Safety biomarkers in preclinical development: translational potential.

Sasseville VG, Mansfield KG, Brees DJ.

Vet Pathol. 2014 Jan;51(1):281-91. doi: 10.1177/0300985813505117. Review.

PMID:
24091814
3.

Predictive biomarkers for personalised anti-cancer drug use: discovery to clinical implementation.

Alymani NA, Smith MD, Williams DJ, Petty RD.

Eur J Cancer. 2010 Mar;46(5):869-79. doi: 10.1016/j.ejca.2010.01.001. Review.

PMID:
20138504
4.

[Translational approach for pharmacogenomics and personalized medicine].

Zhang W, Zhou HH.

Yao Xue Xue Bao. 2011 Jan;46(1):1-5. Review. Chinese.

PMID:
21465801
5.

The biomarker is not the end.

Nohaile M.

Drug Discov Today. 2011 Oct;16(19-20):878-83. doi: 10.1016/j.drudis.2011.08.011. Review.

PMID:
21888986
6.

Clinical translation of cell-based pharmacogenomic discovery.

Cox NJ, Gamazon ER, Wheeler HE, Dolan ME.

Clin Pharmacol Ther. 2012 Oct;92(4):425-7. doi: 10.1038/clpt.2012.115. Review.

7.

Mass spectrometry-based biomarkers in drug development.

Miller RA, Spellman DS.

Adv Exp Med Biol. 2014;806:341-59. doi: 10.1007/978-3-319-06068-2_16. Review.

PMID:
24952191
8.

The role of bioinformatics in diabetes drug development--and precision medicine.

Dangi-Garimella S.

Am J Manag Care. 2014 May;20(8 Spec No.):E1. No abstract available.

9.

Isotopic biomarker discovery and application in translational medicine.

Bayele HK, Chiti A, Colina R, Fernandes O, Khan B, Krishnamoorthy R, Ozda─č H, Padua RA.

Drug Discov Today. 2010 Feb;15(3-4):127-36. doi: 10.1016/j.drudis.2009.12.005. Review.

PMID:
20038454
10.

Biomarkers for the development of new medications for cocaine dependence.

Bough KJ, Amur S, Lao G, Hemby SE, Tannu NS, Kampman KM, Schmitz JM, Martinez D, Merchant KM, Green C, Sharma J, Dougherty AH, Moeller FG.

Neuropsychopharmacology. 2014 Jan;39(1):202-19. doi: 10.1038/npp.2013.210. Review.

11.

Translational paradigms in pharmacology and drug discovery.

Mullane K, Winquist RJ, Williams M.

Biochem Pharmacol. 2014 Jan 1;87(1):189-210. doi: 10.1016/j.bcp.2013.10.019. Review.

PMID:
24184503
12.

Challenges of biomarkers in drug discovery and development.

Goodsaid F.

Expert Opin Drug Discov. 2012 Jun;7(6):457-61. doi: 10.1517/17460441.2012.679615.

PMID:
22471322
13.

Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?

Carden CP, Sarker D, Postel-Vinay S, Yap TA, Attard G, Banerji U, Garrett MD, Thomas GV, Workman P, Kaye SB, de Bono JS.

Drug Discov Today. 2010 Feb;15(3-4):88-97. doi: 10.1016/j.drudis.2009.11.006. Review.

PMID:
19961955
14.

Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization.

Amur S, LaVange L, Zineh I, Buckman-Garner S, Woodcock J.

Clin Pharmacol Ther. 2015 Jul;98(1):34-46. doi: 10.1002/cpt.136. Review.

PMID:
25868461
15.

Biomarkers in Pharmaceutical Research.

Zhao X, Modur V, Carayannopoulos LN, Laterza OF.

Clin Chem. 2015 Nov;61(11):1343-53. doi: 10.1373/clinchem.2014.231712. Review.

16.
17.

Chemical genetics-based target identification in drug discovery.

Cong F, Cheung AK, Huang SM.

Annu Rev Pharmacol Toxicol. 2012;52:57-78. doi: 10.1146/annurev-pharmtox-010611-134639. Review.

PMID:
21819237
18.

General overview: biomarkers in neuroscience research.

Filiou MD, Turck CW.

Int Rev Neurobiol. 2011;101:1-17. doi: 10.1016/B978-0-12-387718-5.00001-8. Review.

PMID:
22050846
19.

Translation of neurological biomarkers to clinically relevant platforms.

Hayes RL, Robinson G, Muller U, Wang KK.

Methods Mol Biol. 2009;566:303-13. doi: 10.1007/978-1-59745-562-6_20.

PMID:
20058180
20.

Regulatory perspective on remaining challenges for utilization of pharmacogenomics-guided drug developments.

Otsubo Y, Ishiguro A, Uyama Y.

Pharmacogenomics. 2013 Jan;14(2):195-203. doi: 10.2217/pgs.12.194. Review.

PMID:
23327579
Items per page

Supplemental Content

Support Center